Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2016 (2016), Article ID 2329483, 6 pages
http://dx.doi.org/10.1155/2016/2329483
Case Report

Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia

1Department of Women’s and Children’s Health, University of Padua, 3 Giustiniani Street, 35128 Padua, Italy
2Pediatric Pain and Palliative Care Service, University of Padua, 59 Ospedale Civile Street, 35121 Padua, Italy
3Department of Medical and Surgical Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
4Rehabilitation Section, Department of Neuroscience, University of Padua, Via Giustiniani 2, 35128 Padua, Italy

Received 11 May 2016; Accepted 28 August 2016

Academic Editor: Yann-Jinn Lee

Copyright © 2016 Chiara Di Pede et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Jundt, “Pathologic-anatomic characteristics of benign bone tumors,” Der Orthopäde, vol. 24, no. 1, pp. 2–14, 1995. View at Google Scholar
  2. D. S. MacDonald-Jankowski, “Fibro-osseous lesions of the face and jaws,” Clinical Radiology, vol. 59, no. 1, pp. 11–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kruse, U. Pieles, M. O. Riener, C. Zunker, M. G. Bredell, and K. W. Grätz, “Craniomaxillofacial fibrous dysplasia: a 10-year database 1996–2006,” British Journal of Oral and Maxillofacial Surgery, vol. 47, no. 4, pp. 302–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Hart, D. H. Schweitzer, P. J. Slootweg, and L. S. J. Grootenhuis, “A male with cherubism,” Nederlands Tijdschrift voor Geneeskunde, vol. 144, no. 1, pp. 34–38, 2000. View at Google Scholar · View at Scopus
  5. W. Zumkeller, A. Jassoy, S. Lebek, and M. Nagel, “Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma,” Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. 5, pp. 553–559, 2001. View at Google Scholar
  6. A. Rastogi, S. K. Bhadada, and A. Bhansali, “Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia,” Indian Journal of Pediatrics, vol. 79, no. 5, pp. 667–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. I. P. S. Kochar and K. P. Kulkarni, “Pamidronate for fibrous dysplasia due to McCune Albright Syndrome,” Indian Pediatrics, vol. 47, no. 7, pp. 633–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Atsali, A. B. Zoubos, K. D. Stathopoulos et al., “Estimation of bone strength parameters and response to treatment in McCune-albright syndrome using peripheral quantitative computed tomography of the tibia,” Journal of Clinical Densitometry, vol. 15, no. 4, pp. 461–466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Bieniasz, A. Maj, and A. Noczyńska, “Fibrous dysplasia of bone in a 12-year old girl,” Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego: Organ Polskiego Towarzystwa Endokrynologów Dziecięcych, vol. 12, no. 1, pp. 69–72, 2006. View at Google Scholar
  10. E. R. Barros, G. L. Saraiva, T. P. de Oliveira, and M. Lazaretti-Castro, “Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta,” Journal of Pediatric Endocrinology and Metabolism, vol. 25, no. 5-6, pp. 485–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. V. V. Khadilkar, A. V. Khadilkar, and G. B. Maskati, “Oral bisphosphonates in polyostotic fibrous dysplasia,” Indian Pediatrics, vol. 40, no. 9, pp. 894–896, 2003. View at Google Scholar · View at Scopus
  12. A. Chattopadhyay, A. Bhansali, S. K. Mohanty, N. Khandelwal, S. K. Mathur, and R. J. Dash, “Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia,” Journal of Pediatric Endocrinology and Metabolism, vol. 16, no. 6, pp. 893–896, 2003. View at Google Scholar · View at Scopus
  13. M. Jayaraman, K. Karikumar, A. Verma, and K. D. Modi, “Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture,” The American Journal of Orthopedics, vol. 40, no. 3, pp. E48–E50, 2011. View at Google Scholar · View at Scopus
  14. A. M. Boyce, M. H. Kelly, B. A. Brillante et al., “A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 11, pp. 4133–4140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Giusti and G. Bianchi, “Treatment of primary osteoporosis in men,” Journal of Clinical Interventions in Aging, vol. 10, pp. 105–115, 2015. View at Google Scholar
  16. B. Ferraz-de-Souza and P. H. S. Correa, “Diagnosis and treatment of Paget's disease of bone: a mini-review,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 57, no. 8, pp. 577–582, 2013. View at Publisher · View at Google Scholar
  17. P. Taxel, P. Choksi, and C. Van Poznak, “The management of osteoporosis in breast cancer survivors,” Maturitas, vol. 73, no. 4, pp. 275–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Graff and T. M. Beer, “Reducing skeletal-related events in metastatic castration-resistant prostate cancer,” Oncology, vol. 29, no. 6, pp. 416–423, 2015. View at Google Scholar · View at Scopus
  19. D. Wu, J. Ma, S. Bao, and H. Guan, “Continuous effect with long-term safety in zoledronic acid therapy for polyostotic fibrous dysplasia with severe bone destruction,” Rheumatology International, vol. 35, no. 4, pp. 767–772, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. L. S. Mansoori, C. P. Catel, and M. S. Rothman, “Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review,” Endocrine Practice, vol. 16, no. 5, pp. 851–854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kos, K. Luczak, J. Godzinski, and J. Klempous, “Treatment of monostotic fibrous dysplasia with pamidronate,” Journal of Cranio-Maxillofacial Surgery, vol. 32, no. 1, pp. 10–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Mäkitie, J. Törnwall, and O. Mäkitie, “Bisphosphonate treatment in craniofacial fibrous dysplasia—a case report and review of the literature,” Clinical Rheumatology, vol. 27, no. 6, pp. 809–812, 2008. View at Publisher · View at Google Scholar · View at Scopus